Survival analysis was performed for the five putative synergistic targets identified from the target intersection i.e. CTSB, MAPK14, MET, PSEN2 and STAT3, in order to assess whether the expression of these genes is associated with overall survival among BC patients. This evidence concerns the gene PSEN2 and breast cancer.